Treasury Yield Jumps over Fed Uncertainty

Jacob Harper  |

The Fed may or may not scale back its bond-buying program. But the fears that they may has caused the market to go skittish on June 21. Fears that a healthy US economy could spell the end on the quantitative easing program (also known as “QE”) have spooked bond investors. The 10-year Treasury yield, which moves inversely to price, was up 3.93 percent to close at 2.5140. And the 5-year note was up even more, ringing in a 7.08 percent increase to close at 1.4060. Both notes have been volatile among uncertainty over what the Fed is going to do regarding purchases going forward, especially the 5-year. The 5-year note was highly erratic, seeing spikes and drops of over 8 percent during the single trading day.

David Ader, chief Treasury strategist at CRT Capital, said "There's a tremendous amount of correlation in these markets right now, as we try to digest the new environment we're in." As Treasury 10-Year Yields hit their highest level in two years and the 5-year its highest in over a year, some analysts have suggested the market’s volatile behavior is temporary overreaction.

Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey said "(The reaction) just shows that the equity market is nervous and would react to any headline at this point."

And Saluzzi’s view that the market is overreacting is certainly gaining traction. Major media outlets have began referring to this fear that the Fed’s stimulus will be tapered off before this has been confirmed and resulting market correction as a “Taper Tantrum.” 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
GARS Garrison Capital Inc. 7.48 -0.02 -0.27 32,610 Trade

Comments


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

World Economic Forum at Davos 2019 - Frank Ricotta CEO BurstIQ

Matt Bird sits down with Frank Ricotta, CEO BurstIQ, at the World Economic Forum at Davos 2019

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.